U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Tenosynovial giant cell tumor

MedGen UID:
232927
•Concept ID:
C1318543
•
Neoplastic Process
Synonyms: Fibrous Histiocytoma of Tendon Sheath; Giant Cell Tumor of Tendon Sheath; Tenosynovial Giant Cell Tumor
SNOMED CT: Giant cell tumor of tendon sheath (95413004); Giant cell tumor of tendon sheath (128777004); Fibrous histiocytoma of tendon sheath (128777004); Tenosynovial giant cell tumor (128777004); Fibrous histiocytoma of tendon sheath (310605004)
 
Monarch Initiative: MONDO:0002522

Definition

A tumor usually arising in the synovium of joints, bursa or tendon sheath. It is characterized by the presence of mononuclear cells, multinucleated osteoclast-like giant cells, hemosiderin-laden macrophages, foam cells, and an inflammatory infiltrate. According to the growth pattern, it is classified as localized or diffuse. [from NCI]

Professional guidelines

PubMed

Updates on the Treatment of Tenosynovial Giant Cell Tumor.
Chan AS, Katiyar V, Dy P, Singh V
Hematol Oncol Stem Cell Ther 2023 May 23;16(4):307-315. doi: 10.56875/2589-0646.1032. PMID: 37363972
CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment.
Wen J, Wang S, Guo R, Liu D
Eur J Med Chem 2023 Jan 5;245(Pt 1):114884. Epub 2022 Oct 29 doi: 10.1016/j.ejmech.2022.114884. PMID: 36335744
Treatment updates on tenosynovial giant cell tumor.
Palmerini E, Staals EL
Curr Opin Oncol 2022 Jul 1;34(4):322-327. doi: 10.1097/CCO.0000000000000853. PMID: 35837703

Recent clinical studies

Etiology

Outcomes of Tenosynovial Giant Cell Tumor of the Foot and Ankle.
Barnett JR, Rudran B, Khan A, O'Reilly-Harbidge S, Patel S, Malhotra K, Cullen N, Welck M, Aston W
Foot Ankle Int 2023 Oct;44(10):1013-1020. Epub 2023 Aug 30 doi: 10.1177/10711007231189491. PMID: 37644900
Tenosynovial giant cell tumor.
Kager M, Kager R, Fałek P, Fałek A, Szczypiór G, Niemunis-Sawicka J, Rzepecka-Wejs L, Starosławska E, Burdan F
Folia Med Cracov 2022;62(2):93-107. doi: 10.24425/fmc.2022.141702. PMID: 36256897
PD-L1 Status in Tenosynovial Giant Cell Tumors.
Zenginkinet T, Faruq AU, Toksoz Yildirim AN, Iyetin Y, Ozturan B, Okay E, Celik A, Ozkan K, Akyurek M
Medicina (Kaunas) 2022 Sep 13;58(9) doi: 10.3390/medicina58091270. PMID: 36143947Free PMC Article
Prospects of Treating Tenosynovial Giant Cell Tumor through Pexidartinib: A Review.
Alsayadi YMMA, Chawla PA
Anticancer Agents Med Chem 2021;21(12):1510-1519. doi: 10.2174/1871520620999201102123555. PMID: 33143617
Tenosynovial giant cell tumor in the foot and ankle.
Çevik HB, Kayahan S, Eceviz E, Gümüştaş SA
Foot Ankle Surg 2020 Aug;26(6):712-716. Epub 2019 Sep 6 doi: 10.1016/j.fas.2019.08.014. PMID: 31526689

Diagnosis

Tenosynovial giant cell tumor.
Kager M, Kager R, Fałek P, Fałek A, Szczypiór G, Niemunis-Sawicka J, Rzepecka-Wejs L, Starosławska E, Burdan F
Folia Med Cracov 2022;62(2):93-107. doi: 10.24425/fmc.2022.141702. PMID: 36256897
PD-L1 Status in Tenosynovial Giant Cell Tumors.
Zenginkinet T, Faruq AU, Toksoz Yildirim AN, Iyetin Y, Ozturan B, Okay E, Celik A, Ozkan K, Akyurek M
Medicina (Kaunas) 2022 Sep 13;58(9) doi: 10.3390/medicina58091270. PMID: 36143947Free PMC Article
Differential Diagnosis of Facet Joint Disorders.
Anaya JEC, Coelho SRN, Taneja AK, Cardoso FN, Skaf AY, Aihara AY
Radiographics 2021 Mar-Apr;41(2):543-558. Epub 2021 Jan 22 doi: 10.1148/rg.2021200079. PMID: 33481690
Optimal Treatment for Tenosynovial Giant Cell Tumor of the Hand.
Kitagawa Y, Takai S
J Nippon Med Sch 2020 Sep 9;87(4):184-190. Epub 2020 Apr 30 doi: 10.1272/jnms.JNMS.2020_87-408. PMID: 32350187
Pigmented villonodular synovitis.
Fałek A, Niemunis-Sawicka J, Wrona K, Szczypiór G, Rzepecka-Wejs L, Cięszczyk K, Burdan M, Puderecki M, Burzec P, Marzec-Kotarska B, Szumiło J, Burdan F
Folia Med Cracov 2018;58(4):93-104. PMID: 30745604

Therapy

Updates on the Treatment of Tenosynovial Giant Cell Tumor.
Chan AS, Katiyar V, Dy P, Singh V
Hematol Oncol Stem Cell Ther 2023 May 23;16(4):307-315. doi: 10.56875/2589-0646.1032. PMID: 37363972
CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment.
Wen J, Wang S, Guo R, Liu D
Eur J Med Chem 2023 Jan 5;245(Pt 1):114884. Epub 2022 Oct 29 doi: 10.1016/j.ejmech.2022.114884. PMID: 36335744
Tenosynovial giant cell tumor.
Kager M, Kager R, Fałek P, Fałek A, Szczypiór G, Niemunis-Sawicka J, Rzepecka-Wejs L, Starosławska E, Burdan F
Folia Med Cracov 2022;62(2):93-107. doi: 10.24425/fmc.2022.141702. PMID: 36256897
Treatment updates on tenosynovial giant cell tumor.
Palmerini E, Staals EL
Curr Opin Oncol 2022 Jul 1;34(4):322-327. doi: 10.1097/CCO.0000000000000853. PMID: 35837703
Pexidartinib: First Approval.
Lamb YN
Drugs 2019 Nov;79(16):1805-1812. doi: 10.1007/s40265-019-01210-0. PMID: 31602563Free PMC Article

Prognosis

Updates on the Treatment of Tenosynovial Giant Cell Tumor.
Chan AS, Katiyar V, Dy P, Singh V
Hematol Oncol Stem Cell Ther 2023 May 23;16(4):307-315. doi: 10.56875/2589-0646.1032. PMID: 37363972
Tenosynovial giant cell tumor.
Kager M, Kager R, Fałek P, Fałek A, Szczypiór G, Niemunis-Sawicka J, Rzepecka-Wejs L, Starosławska E, Burdan F
Folia Med Cracov 2022;62(2):93-107. doi: 10.24425/fmc.2022.141702. PMID: 36256897
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
Fujiwara T, Yakoub MA, Chandler A, Christ AB, Yang G, Ouerfelli O, Rajasekhar VK, Yoshida A, Kondo H, Hata T, Tazawa H, Dogan Y, Moore MAS, Fujiwara T, Ozaki T, Purdue E, Healey JH
Mol Cancer Ther 2021 Aug;20(8):1388-1399. Epub 2021 Jun 4 doi: 10.1158/1535-7163.MCT-20-0591. PMID: 34088832Free PMC Article
Tenosynovial giant cell tumor in the foot and ankle.
Çevik HB, Kayahan S, Eceviz E, Gümüştaş SA
Foot Ankle Surg 2020 Aug;26(6):712-716. Epub 2019 Sep 6 doi: 10.1016/j.fas.2019.08.014. PMID: 31526689
Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis.
Ravi V, Wang WL, Lewis VO
Curr Opin Oncol 2011 Jul;23(4):361-6. doi: 10.1097/CCO.0b013e328347e1e3. PMID: 21577109

Clinical prediction guides

Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies.
Palmerini E, Healey JH, Bernthal NM, Bauer S, Schreuder H, Leithner A, Martin-Broto J, Gouin F, Lopez-Bastida J, Gelderblom H, Staals EL, Mercier F, Laeis P, Ye X, van de Sande M
Oncologist 2023 Jun 2;28(6):e425-e435. doi: 10.1093/oncolo/oyad011. PMID: 36869793Free PMC Article
Update on Tenosynovial Giant Cell Tumor, an Inflammatory Arthritis With Neoplastic Features.
Robert M, Farese H, Miossec P
Front Immunol 2022;13:820046. Epub 2022 Feb 21 doi: 10.3389/fimmu.2022.820046. PMID: 35265077Free PMC Article
Optimal Treatment for Tenosynovial Giant Cell Tumor of the Hand.
Kitagawa Y, Takai S
J Nippon Med Sch 2020 Sep 9;87(4):184-190. Epub 2020 Apr 30 doi: 10.1272/jnms.JNMS.2020_87-408. PMID: 32350187
Tenosynovial giant cell tumor in the foot and ankle.
Çevik HB, Kayahan S, Eceviz E, Gümüştaş SA
Foot Ankle Surg 2020 Aug;26(6):712-716. Epub 2019 Sep 6 doi: 10.1016/j.fas.2019.08.014. PMID: 31526689
Locally Aggressive Connective Tissue Tumors.
Gounder MM, Thomas DM, Tap WD
J Clin Oncol 2018 Jan 10;36(2):202-209. Epub 2017 Dec 8 doi: 10.1200/JCO.2017.75.8482. PMID: 29220303Free PMC Article

Recent systematic reviews

Update on Tenosynovial Giant Cell Tumor, an Inflammatory Arthritis With Neoplastic Features.
Robert M, Farese H, Miossec P
Front Immunol 2022;13:820046. Epub 2022 Feb 21 doi: 10.3389/fimmu.2022.820046. PMID: 35265077Free PMC Article
Treatment, recurrence rates and follow-up of Tenosynovial Giant Cell Tumor (TGCT) of the foot and ankle-A systematic review and meta-analysis.
Siegel M, Bode L, Südkamp N, Kühle J, Zwingmann J, Schmal H, Herget GW
PLoS One 2021;16(12):e0260795. Epub 2021 Dec 2 doi: 10.1371/journal.pone.0260795. PMID: 34855875Free PMC Article
Management of Tenosynovial Giant Cell Tumor: A Neoplastic and Inflammatory Disease.
Healey JH, Bernthal NM, van de Sande M
J Am Acad Orthop Surg Glob Res Rev 2020 Nov;4(11):e20.00028. doi: 10.5435/JAAOSGlobal-D-20-00028. PMID: 33156160Free PMC Article
Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development.
Benner B, Good L, Quiroga D, Schultz TE, Kassem M, Carson WE, Cherian MA, Sardesai S, Wesolowski R
Drug Des Devel Ther 2020;14:1693-1704. Epub 2020 May 4 doi: 10.2147/DDDT.S253232. PMID: 32440095Free PMC Article
Primary diffuse-type tenosynovial giant cell tumor of the spine: a report of 3 cases and systemic review of the literature.
Wang K, Zhu B, Yang S, Liu Z, Yu M, Liu X
Turk Neurosurg 2014;24(5):804-13. doi: 10.5137/1019-5149.JTN.9594-13.1. PMID: 25269059

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...